Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland.
HPB (Oxford). 2006;8(3):216-22. doi: 10.1080/13651820500537739.
p27(kip1) is a tumour suppressor gene, functioning as a cyclin-dependent kinase inhibitor, and an independent prognostic factor in breast, colon, and prostate adenocarcinomas. Conflicting data are reported for adenocarcinoma of the pancreas. The aim of this study was to establish the prognostic value of p27(kip1) expression in adenocarcinoma of the pancreatic head region.
The study included 45 patients (male/female ratio 2:1; mean age 59, range 38-82 years) with adenocarcinomas of the pancreatic head region: 24 - pancreatic head, 18 - periampullary and 3 - uncinate process. The patients underwent the Kausch-Whipple pancreatoduodenectomy (n=39), pylorus-preserving pancreatoduodenectomy (n=5), or nearly total pancreatectomy (n=1). Eight patients received adjuvant chemotherapy postoperatively. Follow-up time ranged from 3 to 60 months. Tumours were staged according to the pTNM classification (UICC 1997). Immunohistochemistry was done on paraffin-embedded blocks from tumour sections. Quantitative determination of p27(kip1) expression was based on the proportion of p27(kip1) -positive cells (< 5% = negative). Survival analysis was carried out using the Kaplan-Meier method and Cox regression model.
Positive p27(kip1) expression was detected in 22 tumours (49%), whereas 23 tumours (51%) were p27(kip1)-negative. There were no significant correlations between p27(kip1) index and stage or lymph node involvement. Median survival time in patients with p27(kip1)-positive tumours was 19 months, whereas in patients with p27(kip1)-negative tumours it was 18 months (p=0.53). A significant relationship was found between p27(kip1)-negative tumours and radical resection (p=0.04). Multivariate survival analysis revealed that the localization of the tumour (pancreatic head/uncinate process vs periampullary) was the only significant and independent prognosticator (p = 0.01, Cox regression model). Resection margins involvement and grade remained nearly significant prognostic factors (p=0.07 and p=0.09, respectively).
We conclude that p27(kip1) has limited overall prognostic utility in resected carcinoma of the pancreatic head region, but its potential role as a marker of residual disease needs to be further assessed.
p27(kip1) 是一种肿瘤抑制基因,作为细胞周期蛋白依赖性激酶抑制剂发挥作用,并且是乳腺癌、结肠癌和前列腺腺癌的独立预后因素。关于胰腺腺癌,有相互矛盾的数据报告。本研究的目的是确定 p27(kip1) 表达在胰腺头部区域腺癌中的预后价值。
该研究包括 45 名男性/女性比例为 2:1 的患者(平均年龄 59 岁,范围 38-82 岁),患有胰腺头部腺癌:24 例胰腺头部,18 例壶腹周围和 3 例胰钩突。患者接受了 Kausch-Whipple 胰十二指肠切除术(n=39)、保留幽门的胰十二指肠切除术(n=5)或近全胰切除术(n=1)。8 例患者术后接受辅助化疗。随访时间为 3 至 60 个月。肿瘤根据 pTNM 分期(UICC 1997)进行分期。免疫组织化学在肿瘤切片的石蜡包埋块上进行。p27(kip1) 表达的定量测定基于 p27(kip1)阳性细胞的比例(<5%=阴性)。使用 Kaplan-Meier 方法和 Cox 回归模型进行生存分析。
检测到 22 个肿瘤(49%)存在阳性 p27(kip1) 表达,而 23 个肿瘤(51%)为 p27(kip1)阴性。p27(kip1) 指数与肿瘤分期或淋巴结受累无显著相关性。p27(kip1)阳性肿瘤患者的中位生存时间为 19 个月,而 p27(kip1)阴性肿瘤患者的中位生存时间为 18 个月(p=0.53)。p27(kip1)阴性肿瘤与根治性切除之间存在显著关系(p=0.04)。多变量生存分析显示,肿瘤的定位(胰头/胰钩突与壶腹周围)是唯一具有显著独立预后意义的因素(p=0.01,Cox 回归模型)。切缘受累和分级仍然是接近显著的预后因素(p=0.07 和 p=0.09)。
我们得出结论,p27(kip1) 在胰腺头部区域切除的癌中总体预后作用有限,但作为残留疾病标志物的潜在作用需要进一步评估。